Treatment of Dark Pigmentation (Hyperpigmentation)
For hyperpigmentation disorders, topical hydroquinone 2-4% remains the first-line treatment, ideally combined with tretinoin 0.05-0.1% and rigorous broad-spectrum sun protection (SPF 15 or greater). 1, 2
Treatment Algorithm
First-Line Topical Therapy
Hydroquinone-based regimens:
- Hydroquinone 2-4% is the established gold standard for treating hyperpigmentation 2, 3
- Combination therapy with tretinoin 0.05-0.1% enhances efficacy, particularly for photoaged skin 2
- Triple combination (hydroquinone + tretinoin + topical corticosteroid) shows superior results for melasma 4
- Treatment duration typically 4-12 months for visible depigmentation 5
Alternative topical agents when hydroquinone is contraindicated or ineffective:
- Azelaic acid 15-20% - comparable efficacy to hydroquinone with less irritation 2, 3
- Kojic acid (alone or combined with glycolic acid) - inhibits tyrosinase activity 2, 3
- Topical corticosteroids - reduce inflammation-mediated pigmentation 3
Essential Adjunctive Measures
Sun protection is mandatory during all hyperpigmentation treatment:
- Broad-spectrum sunscreen SPF 15 or greater applied daily 1
- Protective clothing to cover treated areas 1
- Avoid sun exposure as minimal sunlight sustains melanocytic activity 1
- Without sun protection, repigmentation will occur regardless of treatment 1, 2
Second-Line Interventions
Chemical peels for refractory cases:
- Superficial and medium-depth peels particularly effective in darker skin types 4
- Options include: trichloroacetic acid, Jessner's solution, alpha-hydroxy acids, glycolic acid 2
- Combination regimens with frequent applications show better tolerance in dark-skinned patients 4
Newer modalities:
- Platelet-rich plasma (PRP) shows significant reduction in melasma severity scores 5
- PRP demonstrates higher efficacy than tranexamic acid injections for melasma 5
- Best results when combined with effective home care and sun protection 5
Critical Safety Warnings
Hydroquinone precautions:
- Contains sodium metabisulfite - can cause anaphylactic reactions in sulfite-sensitive individuals 1
- Risk of exogenous ochronosis (blue-black darkening), particularly in Black patients but also Caucasians and Hispanics 1
- Test for skin sensitivity on small patch before full application 1
- Avoid contact with eyes and mucous membranes 1
- Animal studies show carcinogenic potential; human risk unknown 1
- Not recommended during pregnancy (Category C) or in children under 12 years 1
Common pitfalls to avoid:
- Discontinuing sun protection after initial improvement leads to rapid repigmentation 1, 2
- Using hydroquinone without concurrent sunscreen negates treatment benefits 1
- Aggressive treatments in darker skin types risk post-inflammatory hyperpigmentation 4
- Laser therapies can induce hyperpigmentation and recurrences - generally not first-line 2
Treatment Expectations
Realistic timelines:
- Initial depigmentation visible within 4-12 months of consistent use 5
- Maintenance therapy required long-term to prevent recurrence 5, 4
- Melasma typically recurs despite successful treatment 4
- Post-inflammatory hyperpigmentation may resolve with treatment of underlying condition 6
Monitoring requirements: